9/28/2010 12:23:53 PM
September 27, 2010 -- Bayer Schering announced the China launch of Betaferon® (interferon beta-1b), a treatment for relapsing-remitting forms of multiple sclerosis (MS). The drug received SFDA approval for distribution in China last December. Bayer has introduced several products recently as it strives to make good on its promise to increase its revenues at a better than 20% rate. More details....
comments powered by